| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JYHZ2300038 | 恩曲他滨丙酚替诺福韦片(Ⅰ) | emtricitabine;tenofovir alafenamide | Tablet | Chemical Drugs(5.1) | License Renew | 2023-01-28 | Gilead (Shanghai) Pharmaceutical Technology Co Ltd;Gilead Sciences Ireland Uc;Patheon Inc | view | |||
| JYHB1900857 | 恩曲他滨丙酚替诺福韦片(Ⅰ) | emtricitabine;tenofovir alafenamide | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-07-12 | 吉利德（上海）医药科技有限公司 | Gilead (Shanghai) Pharmaceutical Technology Co Ltd;Gilead Sciences International Ltd;Patheon Inc | Filed | 2019-07-24 | view |
| JYHB1901406 | 恩曲他滨丙酚替诺福韦片(Ⅰ) | emtricitabine;tenofovir alafenamide | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-11-28 | 吉利德（上海）医药科技有限公司 | Gilead (Shanghai) Pharmaceutical Technology Co Ltd;Gilead Sciences Ireland Uc;Patheon Inc | Certificate Issued | 2020-02-14 | view |
| JYHB2001779 | 恩曲他滨丙酚替诺福韦片(Ⅰ) | emtricitabine;tenofovir alafenamide | Tablet | Chemical Drugs | Supplementary Application | 2020-09-17 | 吉利德（上海）医药科技有限公司 | Gilead (Shanghai) Pharmaceutical Technology Co Ltd;Gilead Sciences Ireland Uc;Patheon Inc | Filed | 2020-10-12 | view |